Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06225180 · ClinicalTrials.gov registry record
Review of Breast Abscess Management
A clinical trial, sponsored by Methodist Health System.
- Terminated
- Registry status
- 500
- Enrollment target
NCT06225180: Clinical Trial study, sponsored by Methodist Health System.
NCT06225180 is a clinical trial that was terminated before completion, run by Methodist Health System. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06225180 was terminated before completion, sponsored by Methodist Health System.
- TERMINATED
- Registry status
- 500 participants
- Enrollment target
Study Summary
Breast abscesses are an unfortunate pathology that develop in patients, and treatment is often painful and unpleasant. The goal of this study is to identify risk factors associated with failure of aspiration as a primary intervention as opposed to incision and drainage in the hopes of adequately treating patients at initial presentation.
Primary Outcome
Determine the superiority of aspiration vs incision as primary intervention in treatment of breast abscesses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-06-29 |
| Est. Completion | 2025-06-12 |
Why NCT06225180 stopped before completion
NCT06225180 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT06225180 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06225180 about?
NCT06225180 is a clinical study titled "Review of Breast Abscess Management". Breast abscesses are an unfortunate pathology that develop in patients, and treatment is often painful and unpleasant. The goal of this study is to identify risk factors associated with failure of aspiration as a primary intervention as opposed to incision and drainage in the hopes of adequately tre...
What is the current status of trial NCT06225180?
This trial is currently terminated. The enrollment target is 500 participants. The study started on 2023-06-29. Estimated completion is 2025-06-12.
Who is sponsoring clinical trial NCT06225180?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI